Iridex vs Lensar
IRIX and LNSR side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How IRIX and LNSR compare
Lensar is the larger company, worth 5.1 times as much as Iridex ($61.4M against $12.1M).
Iridex grew revenue faster over the last twelve months (3.7% versus 1.6% for Lensar).
Lensar keeps more of each dollar of sales as profit, with a net margin of 56.1% compared with −6.9% at Iridex.
Iridex scores higher on the StockData Score (8 against 7 for Lensar), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | IRIX | LNSR |
|---|---|---|
| Size and price | ||
| Market cap | $12.1M | $61.4M |
| Share price | $0.690 | $5.00 |
| Change, 1 year | −27.7% | −52.0% |
| Change, 5 years | −91.0% | −29.6% |
| Beta (5Y) | 0.93 | 0.59 |
| Employees | 93 | 150 |
| StockData Score | ||
| Total score | 8 (better) | 7 |
| Valuation score | 1 | 1 |
| Growth score | 0 | 2 (better) |
| Performance score | 2 | 2 |
| Health score | 5 (better) | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.2× (better) | 1.0× |
| P/B | 3.3× (better) | 5.6× |
| FCF yield | −16.5% | – |
| Fair value | – | $5.93 |
| Margin of safety | – | 15.7% |
| Growth | ||
| Revenue growth (TTM) | 3.7% (better) | 1.6% |
| Revenue growth, 5Y average | 7.7% | 17.2% (better) |
| Profitability | ||
| Gross margin | 35.9% | 52.0% (better) |
| Operating margin | −5.4% | −3.3% (better) |
| Net margin | −6.9% | 56.1% (better) |
| FCF margin | −3.9% | – |
| Return on equity | −73.1% | – |
| Financial health | ||
| Debt / equity | 0.00 | 0.17 (better) |
| Current ratio | 1.82 | 2.25 (better) |
| Altman Z-score | −2.50 | −0.86 (better) |
| Piotroski F-score | 5 (better) | 3 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 12.4% | 36.0% |
| Held by insiders | 76.1% | – |
| Insider net buying, 12 months | $536K | – |
| Short interest, % of float | 0.94% | – |
Go deeper
- IRIX stock overview
- IRIX income statement
- IRIX valuation and score
- LNSR stock overview
- LNSR income statement
- LNSR valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.